Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Merck Kgaa (MKGAF)

Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of -36% and 1.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

XNCR : 20.11 (-1.81%)
MKGAF : 162.0000 (-0.92%)
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Misses Revenue Estimates

Relay Therapeutics, Inc. (RLAY) delivered earnings and revenue surprises of -11.43% and 42.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RLAY : 6.83 (-2.84%)
MKGAF : 162.0000 (-0.92%)
Profound Medical (PROF) Moves 9.4% Higher: Will This Strength Last?

Profound Medical (PROF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....

PROF : 7.90 (-0.25%)
MKGAF : 162.0000 (-0.92%)
Bears are Losing Control Over Merck KGaA (MKGAF), Here's Why It's a 'Buy' Now

Merck KGaA (MKGAF) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...

MKGAF : 162.0000 (-0.92%)
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of 28.13% and 3.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BCRX : 4.67 (-2.10%)
MKGAF : 162.0000 (-0.92%)
Consumer Price Inflation Really Matters

What CPI index groups should you consult?

MKGAF : 162.0000 (-0.92%)
EC : 11.53 (-1.45%)
BDORY : 10.6600 (-3.44%)
The Zacks Analyst Blog Highlights Banco Do Brasil, Merck KGaA and Ecopetrol

Banco Do Brasil, Merck KGaA and Ecopetrol are included in this Analyst Blog.

MKGAF : 162.0000 (-0.92%)
EC : 11.53 (-1.45%)
BDORY : 10.6600 (-3.44%)
Syntropy Joins MITRE’s Mission to Unlock the Power of Real-World Data for Cancer Research and Treatment

Syntropy , a technology company specializing in healthcare data integration and collaboration solutions, today announced it is joining forces with MITRE to provide data integration support for the mCODE™...

MKGAF : 162.0000 (-0.92%)
PLTR : 21.90 (-3.40%)

Barchart Exclusives

Buy the Dip: A Growth Stock Wall Street Analysts Predict Will Double
Space stocks are a high-risk, high-reward proposition for investors. Here's a look at one name in this burgeoning industry that analysts expect to double. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar